Risk of Restrictions on Business Operations and Supply Due to the Spread of Infection
First written in FY2021. 9 of 11 entries say "Restated". Latest entry: FY2025.
The whole theme swung hardest in 2020: 103 of 175 companies on the "Worse" side.
- FY2025RestatedAnnual report
「If employees become infected due to the spread of COVID-19, influenza or other infectious diseases, or if economic conditions deteriorate, the performance and financial position of our group could be affected.」
The company continues to disclose the possibility that employee infections caused by the spread of infectious diseases and deteriorating economic conditions could affect performance. - FY2024RestatedAnnual report
「If employees become infected due to the spread of COVID-19, influenza or other infectious diseases, or if economic conditions deteriorate, the performance and financial position of our group could be affected.」
The company continues to disclose the possibility of infectious diseases, including COVID-19, affecting performance. - FY2023RestatedAnnual report
「If employees become infected due to the spread of COVID-19, influenza or other infectious diseases, or if economic conditions deteriorate, the performance and financial position of our group could be affected.」
The company continues to disclose the possibility of infectious diseases, including COVID-19 and influenza, affecting performance. - FY2023-Q3RestatedAnnual report
「With respect to the impact of COVID-19 on the business, we will continue to closely monitor developments.」
The company continues to maintain its policy of closely monitoring the impact of COVID-19 on the business. - FY2023-Q2RestatedAnnual report
「There were no newly arising business or other risks during the six-month period ended 30 September 2020. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year. With respect to the impact of COVID-19 on the business, we will continue to closely monitor developments.」
The company states that there are no new risks or material changes to existing risks, and that it will continue to closely monitor the impact of COVID-19 on the business. - FY2023-Q1RestatedAnnual report
「The impact of the spread of COVID-19 on our business and other operations could affect our financial position and operating results in the future, depending on when the COVID-19 pandemic subsides and how other circumstances develop.」
The company continues to disclose the possibility of future effects on performance from COVID-19. It also explains the easing of restrictions on activities and signs of a return to normal economic activity. - FY2022RestatedAnnual report
「As for the impact at this point, delays have occurred in the supply of some components. However, we have taken measures to address the issue, and we believe that no event has occurred under current conditions that would materially affect the performance of our group.」
Delays in component supplies continue, but the company continues to believe that no event has occurred at this point that would materially affect performance. - FY2022-Q3RestatedAnnual report
「Our group has taken measures to reduce infection risks, including refraining from nonessential and nonurgent business trips and meetings and encouraging working from home and staggered working hours. At the same time, all business divisions have continued their activities to ensure a stable supply of the products manufactured by our group. At present, there is no direct impact on our group's financial position, operating results or cash flows. However, if infections with COVID-19 occur within our group in the future, our financial position, operating results and cash flows could be affected, including through the temporary suspension of operations.」
The company continues to implement measures to reduce infection risks and maintain the activities of all business divisions and the stable supply of its products. It also continues to believe that there is currently no direct impact on its financial position, operating results or cash flows. - FY2022-Q2RestatedAnnual report
「Our group has taken measures to reduce infection risks, including refraining from nonessential and nonurgent business trips and meetings and encouraging working from home and staggered working hours. At the same time, all business divisions have continued their activities to ensure a stable supply of the products manufactured by our group. At present, there is no direct impact on our group's financial position, operating results or cash flows. However, if infections with COVID-19 occur within our group in the future, our financial position, operating results and cash flows could be affected, including through the temporary suspension of operations.」
The company continues to implement measures to reduce infection risks and maintain the activities of all business divisions and the stable supply of its products. It also continues to believe that there is currently no direct impact on its financial position, operating results or cash flows. - FY2022-Q1MitigatedAnnual report
「Our group has taken measures to reduce infection risks, including refraining from nonessential and nonurgent business trips and meetings and encouraging working from home and staggered working hours. At the same time, all business divisions have continued their activities to ensure a stable supply of the products manufactured by our group. At present, there is no direct impact on our group's financial position, operating results or cash flows. However, if infections with COVID-19 occur within our group in the future, our financial position, operating results and cash flows could be affected, including through the temporary suspension of operations.」
The company states that it has continued the activities of all business divisions and the stable supply of its products while implementing measures to reduce infection risks, and that there is currently no direct impact on its financial position, operating results or cash flows. However, the possibility remains that operations could be temporarily suspended if infections occur within the company. - FY2021First statedAnnual report
「As for the impact at this point, certain business activities have been restricted and delays have occurred in the supply of some components. However, we have taken measures to address these issues, and we believe that no event has occurred under current conditions that would materially affect the performance of our group.」
Restrictions on business activities and delays in component supplies have occurred, but we do not believe that any event has had a material impact on performance. We have implemented remote work, staggered working hours and early ordering.